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Abstract. 
 
Non-nucleosidic anthracene-functionalised phosphoramidites 5a and 
5b have been synthesised.  5b  has been incorporated into oligonucleotide 
sequences  (PrA, PrB, PrC, PrD, PrE, PrF and PrG) as a DNA base 
analogue using automated synthesis.  
 
Melting temperature (Tm) studies of double-stranded 15-mer / 14-mer 
deletion sequences compared to 15-mer / 15-mer analogues demonstrated 
that the incorporation of anthracene serves to stabilise the duplexes by 
improved intercalation in the former case.   
 
PrA, was used as a probe for detection of base pair mismatches in 
target DNA sequences using fluorescence spectroscopy.     Titration of PrA 
versus a range of matched target oligonucleotides (TarAx where x = 1 - 5) 
demonstrated an enhancement in anthracene fluorescence when adenine 
was positioned adjacent to the anthracene tag on the opposite strand for 15-
mer / 15-mer duplexes . Titration of PrA versus a range of mismatched target 
oligonucleotide sequences (TarBx, TarCx, TarDx, TarEx, TarFx and TarGx 
where x = 1 - 2) demonstrated enhancements in emission for C-A, C-T and C-
C mismatches, which were dependent on mismatch position (5’ or 3’) in the 
target strand.  The latter effect is possibly due to the chiral nature of 5b.  
Probes such as PrA show potential for use as sensors for single nucleotide 
polymorphisms (SNPs) in DNA sequences. 
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Abbreviations 
  
DNA   Deoxyribonucleic acid 
RNA  Ribobucleic acid 
AIDS  Acquired immune deficiency syndrome 
HIV  Human immunodeficiency virus 
BACE β-site APP cleaving enzyme 
AD  Alzheimer’s disease 
SNP  Single nucleotide polymorphism 
A  Adenine 
G  Guanine 
C  Cytosine 
T  Thymine 
U  Uracil 
mRNA Messenger RNA 
tRNA  Transfer RNA 
BC  Beaucage-Caruthers 
DMTr Dimethoxytrityl 
BDF  Base-discriminating fluorescent- 
PyBOP Benzotriazol-1yl-oxytripyrrolidinophosphonium 
hexafluorophosphate 
HOBt  1-hydroxybenzotriazole 
HBTU O-benzotriazole-N,N,N’,N’-tetramethyuronium 
hexafluorophosphate 
NMR Nuclear magnetic resonance 
δ Chemical shift (NMR) 
m/z Mass-to-charge ratio 
DMAP Dimethylaminopyridine 
HSQC High-spin quantum correlation 
HPLC High-performance liquid chromatography 
UV-Vis Ultraviolet-visible 
VT-NMR Variable temperature NMR 
ppm Parts per million 
MS Mass spectrometry 
HRMS High-resolution mass spectrometry 
ES Electrospray ionisation 
Tm Melting temperature (nucleic acid duplex) 
IR Infra-red 
Rf Retention factor 
DCM Dichloromethane 
MeOH  Methanol 
DMF N,N’-dimethyl formamide 
 ii 
 
NMR multiplicities 
 
s  Singlet 
d Doublet 
t Triplet 
q Quartet 
dd Doublet of doublets 
m Multiplet 
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1.0. Introduction 
1.1. Background. 
  
Nucleic acids are arguably the most important class of biomolecules 
that exist within the cells of living organisms.  Governing the expression of 
proteins within a cell, it is nucleic acids that provide the blueprint for an 
individual organism's biochemistry.    Only a single copy of the blueprint exists 
per cell, and it is this genetic code that is replicated and passed on by parent 
to daughter cells during cell division.   When organisms engage in sexual 
reproduction to produce offspring, half the genetic material from one parent 
and half from the other parent is passed to the progeny.  In this way 
descendants inherit the genetic code with equal contribution from their parent 
ancestors.    
 
Nucleic acids are also crucial in the development of a species as a 
whole.  Sections of nucleic acids called genes encode for larger regions that 
determine the outward physical characteristics of an organism.    Hence such 
qualities as skin and eye colour and athletic / intelligence potential are 
partially controlled by the sequence of nucleic acids contained within a cell – 
some characteristics require exposure to the correct environmental input, e.g. 
physical training or learning, to fulfil the genetic potential.  Mutations within the 
nucleic acid palette can therefore produce new traits in an organism.  If these 
new qualities are desirable, they can be passed down from generation to 
generation until only the strongest organisms remain to flourish.  Nucleic acids 
are therefore the underlying basis of the idea of Darwinian 'survival of the 
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fittest'.  It is the survive-inherit process that is directly responsible for evolution 
of species, of which there are many examples e.g. the white fur of polar 
bears, immunity to pesticide in parasitic aphids, resistance of bacteria to an 
antibiotic, the active sites of proteins (which catalyse perfect chemical 
reactions) or the ultimate example of the human brain. 
 
The examples above are of nucleic acids in working order and 
functioning normally, and as described above, mutation can be a benefit to an 
organism in certain cases.  However, the mutation of nucleic acids1 can also 
lead to disease.  There are various types of lesions that can occur in nucleic 
acids; most are caused by non-innate external stimuli, such as mutagenic 
chemicals (e.g. the intercalating hydrocarbons found in cigarette smoke), 
ionising radiation (e.g. UV light, X-rays or nuclear radiation), radical oxygen 
species or through pathogenic retroviruses such as the human immuno-
deficiency virus (HIV).   This category of mutation is known as somatic 
mutation,2 and is passed on from parent to daughter cells during cell division 
(mitosis), via DNA replication.  Exposure of an individual's genome to the first 
three examples primarily results in diseases such as cancer, a state in which 
the normal pathways for controlling cell senescence and proliferation have 
broken down; cells divide rapidly and uncontrollably to produce tumours which 
eventually overtake and kill the organism if left untreated.  Examples are the 
common skin cancer malignant melanoma which is primarily caused by 
exposure to the UV rays in sunlight and lung cancer in cigarette smokers 
caused by the polycyclic aromatic hydrocarbons ('tar') contained within the 
inhaled smoke.  It is a miracle of existence that the body is extremely efficient 
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at repairing somatic mutations on an almost daily basis.  The previous two 
centuries have seen the first real leap in life expectancy due to better 
sanitation and healthcare, but perversely it has also led to the indomitable rise 
of mortality from cancer, due to breakdown of the DNA repair pathways in the 
latter stages of an individual's life due to old age. Similarly, individuals 
exposed to HIV have their genetic material changed to incorporate the viral 
genetic material by the virus' nucleic acids and an enzyme known as reverse 
transcriptase.  The result, after an incubation period, is a condition known as 
acquired immune deficiency syndrome (AIDS), where an individual elicits no 
immune response to pathogenic infection.   
 
In some unfortunate individuals, diseases or susceptibility to diseases 
are simply inherited from the genetic material from their ancestors.3   
Diseases such as Huntington's disease,4 Down's syndrome,5 sickle-cell 
anaemia,6, Swedish variant Alzheimer's disease,7 diabetes,8 juvenile 
glaucoma,9 and colon cancer,10 are all examples of diseases where the 
condition (or a susceptibility to the disorder in the latter four examples) is 
inherited by the offspring.    Genetic susceptibility to cancer is determined by 
regions of nucleic acids sequence popularly described as oncogenes.   
Mutated DNA inherited by the progeny from the parent are called germ-line 
mutations. 
 
 It is clear then that a deep understanding of nucleic acid chemistry will 
be useful for the future of medicine in the identification of new and novel 
drugs, therapies and treatments for disease.   We will therefore discuss the 
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chemistry of nucleic acids and then consider how the genetic blueprint is used 
to create proteins, and in doing so we will shed light on why nucleic acids are 
the ultimate controllers of cellular chemistry. 
 
1.2. Nucleic acid structure 
 There are two components to nucleic acid structure:  the heterocyclic 
bases and the sugar-phosphate diester 'backbone'.  There are five natural 
bases: the purines guanine (G) and adenine (A), and the pyrimidines cytosine 
(C), thymine (T), and uracil (U).  The first four bases exist in deoxyribonucleic 
acid (DNA), and in ribonucleic acid (RNA), uracil replaces thymine (uracil 
differs from thymine by a hydrogen in place of the methyl group on the 
pyrimidine ring).   Certain pairs of these heterocyclic bases are able to make 
complementary hydrogen bonds to each other (Figure 1.1), G—C and A—T 
(U in RNA).  It is worth noting that the G—C base pair is stronger than the A—
T base pair due to the number of hydrogen bonds. 
 
 
 
 
Figure 1.1: Watson- Crick base pairing in nucleic acids. 
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    When the bases are incorporated into a sugar-phosphate backbone made 
up, not surprisingly of phosphate esters of sugar (the sugar in DNA is 
deoxyribose, whereas in RNA it is ribose), the effect is to create a 'zipper' of 
bases that can bind to a complementary strand through hydrogen bonding. 
The binding effect is cooperative, and leads to a stable double-stranded 
structure that is right-handed helical under normal base-pairing conditions 
(sometimes known as Watson and Crick base pairing), the helix is known as 
the B-form, and contains major and minor grooves.   The sense strand is said 
to run from 3' to 5' based on the numbering of the sugar atoms in the 
backbone.  The complementary antisense strand is then said to run from 5' to 
3' if the same direction is considered. It is worth noting that nucleic acids 
behave as macromolecular polyanions in aqueous solution due to the 
negatively charged phosphate groups in the backbone of both strands. 
(Figure 1.2).    
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Figure 1.2:  Top: Simplified molecular structure of single strand DNA sequence CTC (3’ 5’) 
paired with a complementary single strand DNA sequence of GAG (5’ 3’) to make a double 
stranded DNA oligomer. Bottom: Helical B-DNA structure proposed by Watson and Crick.11 
 
 
Major Groove 
 
Minor Groove 
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1.3. The genetic code. 
The role of nucleic acids in chemical biology is vital: the DNA contained 
within the cell nucleus (genotype) is paramount in deciding the characteristics 
that an individual organism exhibits (phenotype).  This is because the DNA is 
a molecular blueprint for the proteins produced by every cell, and as proteins 
determine the reactions that a cell can carry out, determines chemistry in vivo. 
The DNA of the cell is therefore said to carry the genetic code of an organism. 
The DNA within the cell is packaged by histone and scaffold proteins; the final 
macromolecular structures are called chromosomes.    
 
The conversion of DNA to protein12 however is not straightforward, 
requiring intermediate molecules to relay chemical information in a process 
known as transcription.   During this process, the DNA base pairs unzip within 
the nucleus and the enzyme RNA polymerase makes complementary RNA 
strands to the DNA sense strands using the RNA nucleotides.  The single 
stranded molecule that is formed is known as messenger RNA (mRNA).  The 
mRNA then leaves the nucleus and proceeds into the cytoplasm, where the 
protein synthesis process known as translation begins.  During translation, the 
mRNA sequence is converted into protein.  This takes place on structures 
known as ribosomes, which are made up of protein and ribosomal RNA.  The 
ribosomes ‘read’ the mRNA genetic code as a triplet frame of bases – these 
are known as codons.  Each triplet codon is then paired up with its 
complementary triplet anticodon contained within a molecule known as 
transfer RNA (tRNA).  The pairing up is catalysed by the ribosome, which acts 
as a matrix for the reaction.  The small tRNA molecules each bear a single 
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amino acid corresponding to a certain codon/anticodon combination; some 
combinations encode for ‘start’ or ‘stop’ functions so that the translation can 
be controlled (Table 1.1).  In this way the 20 amino acids are coded for by the 
4 DNA/RNA bases.  Catalytic condensation of the amino acids into a 
polypeptide chain followed by hydrolysis of the growing chain’s bonds to the 
tRNA molecule then follows.  This completes the in vivo process of protein 
synthesis from a DNA sequence.  
 
Table 1.1:  mRNA triplet codon sequences and the corresponding amino acid produced post-
translation.1  
 
 
1.4. DNA: the blueprint for cell chemistry. 
Many of the proteins contained within the genetic code are enzymes 
which orchestrate cell chemistry.  Enzymes are biological catalysts, which in 
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the traditional definition means an entity that speeds up a chemical reaction 
without itself being used up.  From the selectivity demonstrated by terpene 
cyclases13 in plant secondary metabolism on relatively featureless 
hydrocarbon substrates to the superlatively rapid catalytic activity 
demonstrated by human carbonic anhydrase (over 109 turnovers per second 
and hence diffusion controlled),14 enzymes perform perfect chemical reactions 
within the cell, honed by millions of years of evolution.  The way in which 
proteins are folded, which in itself is a direct result of the amino acid sequence 
(and that is determined by DNA base sequence) determines which reactions 
can be catalysed.  Sometimes co-factors, such as metals, are involved.  The 
centres of chemical reactivity contained within a protein's three-dimensional 
structure are known as active sites.  Within the active site, reactions that 
usually are recalcitrant become facile, and slow reactions become rapid, 
usually at around 37 °C for all warm-blooded organisms (this latter fact is 
usually cited as evidence of a common ancestor between species).    
 
An important topical example of protein pathogenicity through mutation 
of DNA is that of Alzheimer's disease (AD).   β – site APP cleaving enzyme 
(BACE) catalyses the hydrolysis of amide bonds in vivo.  In its normal 
biological role BACE is thought to be responsible for control of myelination of 
axons. However, BACE is also inadvertently responsible for causing AD in 
humans.15 The  active site of BACE, when mutated, can also catalyse the 
cleavage of the membrane-bound amyloid precursor protein (APP) in vivo; 
subsequent catabolism of the C99 peptide from this reaction produces the 
Aβ42 polypeptide which is primarily responsible for generating the neural 
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plaques that cause AD.    In the hereditary Swedish variant of AD it has been 
proven that mis-sense mutations (see later) to DNA are to blame for the final 
pathogenic activity of the protein.16  There are now potent inhibitors of BACE 
being developed to prevent onset of the disease,17 and identification of an 
individual's susceptibility via screening for the mutated DNA sequences will be 
crucial to the success of any forthcoming therapies. 
 
The latter example quite clearly demonstrates that it is DNA that, in 
reality, controls the chemistry of the cell, as the protein sequences expressed 
by a cell are determined solely by the DNA contained within every cell 
nucleus.  One thing is also clear, in that DNA provides a much better target for 
drug molecules etc. as only one copy of the genetic code exists within the cell 
nucleus of every cell – target this effectively and a disease may be 
successfully cured/treated;  this is the basis of gene therapy.    
 
1.5. Genetic Mutations. 
 Structural changes to DNA are known as genetic mutations.  Naturally, 
these exist to give variation in the gene pool.  As we have seen, some genetic 
mutations can be advantageous, while others are the basis of disease or lead 
to evolutionary throwback, with natural selection rapidly eliminating the weak 
gene.     
 
There are a range of genetic mutations which can occur to disrupt the 
sequence of cellular DNA.   Point mutations, often referred to as single 
nucleotide polymorphisms (SNPs), are mutations in which a single nucleotide 
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in a DNA sequence is exchanged for another nucleotide, containing a different 
base.18   Purine – purine (A, G) or pyrimidine – pyrimidine (C, T) exchange 
type mutations are most common simply due to the hydrogen bonding 
differences of the base pairs in DNA; although purine – pyrimidine exchange 
is possible, it is much less common as a result.  It can be seen from Table 1 
that the base exchanged may or may not influence the amino acid produced 
by an mRNA codon.    The third (wobble) position in the codon is far more 
tolerant to change than for mutation at positions one or two in the triplet 
sequence.  Any mutation that changes an amino acid in a protein sequence is 
known as mis-sense mutation.  Mutations that code for the same amino acid 
are called silent mutations, as no effect can be discerned; proteins are 
unchanged by the mutation.  The final type is the non-sense mutation, where 
the mutation codes for the UAA, UAG or UGA mRNA stop codons which then 
cut the protein sequence short at that point.     
 
Single nucleotide polymorphisms are the basis of many medical 
conditions.  The protein tumour suppressor P53 is integral to regulating the 
senescence and apoptosis (cell death) of any potential tumour cells.     
Breakdown of the P53 repair pathway is associated with uncontrolled cell 
cycles and hence almost every type of cancer in humans.  The TP53 gene 
which encodes for protein P53 is susceptible to SNPs, with over 200 sites for 
potential SNPs identified.   Two of these SNPs produce the R72P, and P47S 
mutant P53 proteins which are associated with the onset of tumour growth 
(tumourigenesis).19  Similarly, an SNP of the mIR-146 gene was identified 
recently in a number of ovarian cancer patients.20    
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 The second category of DNA mutations arise from frameshift 
mutations.  These are caused by the insertion or deletion of a DNA base or 
large sections of DNA bases within the sequence and hence, because the 
process of transcription imposes a three-base reading frame on the DNA 
sequence, the whole gene sequence encodes for completely new amino acids 
and therefore mutated proteins of unknown or no function.    In some cases, 
this can be detrimental to normal cellular function:  returning to the example of 
the p53 tumour suppressor protein, a 16 base pair insertion into intron 3 
(where an intron is a section of DNA that encodes for protein) of the TP53 
gene is associated with tumourigenesis.19 
 
It is crucial, therefore, that new methods are to be developed for 
screening of mutated genotype to determine disease phenotype.21  The 
fruition of the human genome project22 has allowed the mapping of the DNA-
containing chromosomes enclosed within our cells, and this has subsequently 
enabled researchers to target the genes responsible for diseases.      
 
1.6. Screening for polymorphisms. 
SNPs are a good objective for genotype-phenotype studies due to the 
relative simplicity of the mutation, as detection of a polymorphism in one base 
pair is much easier on a molecular scale compared to detection of a full 
frameshift mutation, which may have large areas of mutated or deleted DNA.  
As we have also seen, they are responsible for a range of diseases relevant 
to morbidity in the modern age, so they are attractive targets for research:  the 
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challenge remains to find the best ways to analyse for these genetic 
mutations.  We can, in theory, sequence an entire individual's DNA using 
traditional gene-sequencing techniques such as Sanger sequencing, which is 
based on DNA chain termination with fluorescent dideoxynucleotides that 
reveal the identity of bases in a sequence by four colour outputs 
corresponding to each base.23  However, despite the widespread use of this 
type of sequencing for biochemical research purposes worldwide, this simply 
would take too much time to perform on an entire population.    Any potential 
analyses must be rapid, selective and sensitive enough to be used routinely, 
without incurring a large cost. 
 
 Designing fluorescent tags for incorporation into biologically relevant 
molecules has been a popular research topic for many years.  Due to the 
quantitative nature of fluorescence, i.e. measurable energy input and output, it 
has been used to great effect as a structural probe in biomolecules. Both DNA 
and proteins/polypeptides, have been labelled with fluorescent labels.  Usually 
in such studies, a photoactive molecule is appended to a biomolecule either 
by a site-specific chemical reaction that forms a covalent bond between the 
biomolecule and the label itself (usually referred to as bioconjugate 
chemistry), or the biomolecule itself can be synthesised artificially to contain 
the label / sensor using a protection-deprotection type approach, either in 
solution or on solid-phase supports.     
 
The Beaucage-Caruthers (BC) approach to the synthesis of 
oligonucleotides24 is one of these stepwise approaches which has been used 
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to synthesise artificial oligonucleotides in vitro.   The approach uses 
nucleotide diols in the synthetic cycle, though in theory any diol can be 
incorporated into the growing DNA chain.  The nucleotides can be reacted 
with certain directionality as one of the alcohol oxygens in the diol group is 
usually mono O-protected with a dimethoxytrityl (DMTr) protecting group, 
while the other hydroxyl is used in the form of an activated phosphoramidite, 
which can undergo nucleophilic substitution at phosphorus.  The synthetic 
cycle is performed on solid supports and is summarised in Scheme 1.1. 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1.1:  A typical cycle in a Beaucage-Caruthers (BC) type in vitro synthesis of 
oligonucleotides (X= H for DNA, X = OH for RNA).25 
 
Once incorporated, the label, which must retain its fluorescent 
character, is then irradiated at the specific wavelength so that the 
chromophore absorbs a large cross-section of photons.  Once the excited 
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state is populated, a number of processes can happen to release the energy 
absorbed.  One such process, fluorescence, leads to the emission of a photon 
at a higher wavelength (Stokes shift).  Strictly speaking, the latter process 
must arise from the transition from an excited singlet state to the ground   
singlet state.26 The molecular fluorescence described is usually highly 
dependent on factors such as solvent polarity and molecular orientation; as 
such, detection of minute changes in the local environment around a 
fluorescent tag is possible when fluorescent groups are incorporated into a 
biomolecule. In some cases, computational methods can be used either to 
predict or interpret results.  Modern fluorimeters allow the selection of 
wavelengths of light appropriate for the excitation of labels by the use of 
highly accurate monochromators.  Benchtop machines are now available due 
to the miniaturisation of computer parts.  The increase in the use of affordable 
laser instrumentation allows use of intense pulsed or continuous-wave 
monochromatic light in everyday experiments.  Finally, as fluorescence is 
essentially a dark-background technique, it offers superior sensitivity to many 
other spectroscopic techniques, with detection of signal possible well into the 
picomolar concentration range. 
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1.7. Fluorescent sensors for single nucleotide polymorphisms.  
 There have been a myriad of reports of sensors which use 
fluorescence to detect single nucleotide polymorphisms in DNA sequences.  A 
review of the scientific literature is appropriate to look at the evolution of such 
probes in terms of their selectivity and sensitivity, and to highlight the various 
approaches which can be used to modify DNA to incorporate such useful 
reporter groups.    Although a number of approaches18 have been developed 
toward this end, including fluorescent sequence-specific DNA primers,27    
post-synthetic site-specific labelling of DNA,28 molecular beacons,29 dual 
probe assays30 and hybridisation probes.27   This review is limited to 
consideration of hybridisation probes where modification or substitution of 
nucleotides with fluorescent groups on single probe sequences is used to 
detect single base pair mismatches with double stranded DNA due to the 
relevance to the work performed in our laboratories described later.   
 
 Oligonucleotides are short lengths of single-stranded DNA, 
incorporating usually less than 30 bases.  One of the earliest examples of the 
incorporation of a fluorescent hydrocarbon into an oligonucleotide sequence 
was reported by Yamana and co-workers,31 who, by using the BC 
phosphoramidite method were able to label short oligonucleotides with 
methylpyrene groups at the 3' and 5' termini which remained fluorescent after 
modification.  Upon binding of the labelled oligonucleotides with 
complementary sequences, it was demonstrated that the pyrene fluorescence 
was perturbed.    
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 These early studies demonstrated the usefulness of the aromatic 
hydrocarbon groups as fluorescent reporters due to their sensitivity to local 
environment; pyrene emission is known to be enhanced in polar environments 
but quenched in non-polar environments.32   It also has the ability to form an 
excimer (an excited state dimer) which drastically change the pyrene emission 
spectrum, giving output of light at much higher wavelengths (lower energies).  
A study was reported by Balakin et al. on the incorporation of pyrene groups 
into oligonucleotides33  Dual pyrene chromophores (Figure 1.3) were 
incorporated in the centre of an oligonucleotide sequence, 5'-
CCCCTAG(Per)2CCTGTA-3'.  A second non-labelled complementary 
sequence was also synthesised, 5’-TACAGGTCCTAGGGG-3’.  Drastic 
changes to the pyrene fluorescence were observed upon hybridisation of the 
complementary sequences, which were ascribed to excimer formation 
between the neighbouring fluorescent groups.  The structural framework 
imposed by hybridisation of the strands caused the formation of the excimer 
and the output of light as the signal.  Although such hybridisation probes had 
not yet addressed base-pair mismatches as such, it was clear at this point 
that slight modifications to the systems could lead to very useful applications. 
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Figure 1.3:  Pyrene groups incorporated into an oligonucleotide strand.33 
 
 Modification of bases with pyrene chromophores has since been a 
popular synthetic approach to base-discriminating fluorescent (BDF) 
nucleotides.  Such artificial nucleotides display changes in fluorescence 
output when paired with non-matching bases upon hybridisation to duplex.  
Saito and co-workers performed a chemical modification of 7-de-aza-
adenosine under Sonagashira conditions to incorporate a pyrene moiety 
directly attached to the adenosine nucleobase analogue (Figure 1.4).34 
Hydrogenation of the alkynyl bond, then protection at the 5'-OH position on 
the deoxyribose ring with dimethoxytrityl, followed by the formation of the 
activated phosphoramidite at the 3'-OH allowed the fluorescent base 
analogue PyA to be used in the DNA synthesis cycle, incorporated into the 
oligonucleotide sequence 5'-CGCAATPyATAACGC-3'.   Four complementary 
sequences were also synthesised during the study with the general sequence 
5'-GCGTTAXATTGCG-3', where X = T, C, A or G.   
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Figure 1.4:  Synthetic nucleotide  PyA for distinction of thymine in protected form prior to DNA 
synthesis.34 
 
 It was found that, upon hybridisation of the PyA strand to the latter four 
sequences, striking changes occurred in the fluorescence of the pyrene.  
When X = A, C or G it was found that the pyrene emission at 390 nm was not 
perturbed by any reasonable amount compared to the 5'-
CGCAATPyATAACGC-3' strand.  However, upon hybridisation with the strand 
with correct Watson-Crick base pair (T) opposite to the PyA residue i.e. a fully 
complementary sequence, that the emission was effectively switched off, 
being 100-fold less efficient than the fluorescence of the single stranded 5'-
CGCAATPyATAACGC-3' sequence alone.  The mechanism of the quenching 
was believed to arise from intercalation (the incorporation of planar, usually 
aromatic molecules, into DNA by their slotting between the hydrogen bonded 
bases perpendicular to the 5' to 3' sugar phosphate z-axis) of the pyrene unit 
into the double stranded DNA.  Under mismatch conditions i.e. when X = A, C 
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and G the pyrene did not intercalate, probably due to steric blocking of the 
mismatched base pair.  As the signal is switched on under the condition of 
base mismatch the potential of such BDF nucleotides as sensors for SNPs is 
clear; less clear from first glance were the driving forces behind the 
remarkable behaviour.   As the studies were carried out in aqueous systems, 
the pyrene, if not intercalated is exposed to the polar bulk solvent, and 
remains fluorescent.  However, with a matched base pair, order is restored to 
the helix and a site for intercalation is produced.  When slotted between the 
bases, the pyrene is in effectively a hydrophobic and non-polar environment, 
and as such the fluorescence was effectively turned off.   Computational 
modelling also supported the intercalation argument, with the intercalated 
pyrene in theory conferring additional stability to the duplex.   This was 
backed up by melting temperature experiments on the duplexes and by the 
UV absorption spectrum. The intercalated pyrene unit showed a red-shift in its 
absorbance spectra due to π stacking interactions with the bases above and 
below.  The melting temperature of a DNA duplex (Tm), i.e. the temperature at 
which the DNA duplex is half-dissociated, is indicative of the stability of the 
double stranded oligonucleotide.  In this case, the 5'-CGCAATPyATAACGC-3' 
/  5'-GCGTTATATTGCG-3' duplex was more stable than the wild type 5'-
CGCAATATAACGC-3' /  5'-GCGTTATATTGCG-3' duplex, supporting the 
intercalation argument.      Further work by Saito and co-workers used similar 
strategies to that described presently.   A whole range of base-discriminating 
fluorescent nucleosides were synthesised35 to complement the original PyA 
nucleoside, again using pyrene as the organic reporter group in various 
guises (Figure 1.5).    By changing the structure of the fluorescent nucleoside, 
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varying base-discriminating properties were conferred.  PyU, based on a 
pyrene attached to a uracil nucleobase was found to give a sizeable increase 
in fluorescence quantum yield for an adenine (A) at the adjacent position in 
the antisense strand of an oligonucleotide duplex.32c   Likewise, the cytosine 
analogue PyC gave a substantial and highly selective increase in fluorescence 
when the adjacent base was guanine (G).  The fluorescence behaviour of 
these sensors was opposite to the behaviour of PyA.    PyU and PyC acted as 
'turn-on' sensors for a base-pair match, whereas PyA acted as a 'turn-on' 
sensor for a base-pair mismatch.  The difference in behaviour arose from the 
rigid propargyl linker in PyU and PyC.  The molecular conformations meant that 
it was impossible for the pyrene group to intercalate under normal base-
pairing conditions, being effectively extruded from the interior of the DNA 
duplex by the rigid propargyl group, and so fluorescence was turned on in the 
polar environment of the bulk solvent; the authors deliberately chose the 
position of the labelling for this reason alone. The base-discriminating 
nucleosides 8PyA and MePydA displayed the same behaviour with thymine (T) 
and cytosine (C), thus giving the authors the ability to detect SNPs for any 
mismatch type. 35 
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Figure 1.5:  Structures of base-discriminating fluorescent nucleosides.35 
 
The BDF nucleoside probes PyC and PyU were later described by 
Okamoto et al. for use in a simple fluoroassay for detection of SNPs.36    The 
human gene sequence BRCA1, an oncogene associated with breast cancer, 
is known to contain a G to A point mutation SNP.  The BRCA1 gene was 
firstly amplified by polymerase chain reaction (PCR – a method to amplify 
pieces of DNA see Saiki et al.37 for further details) then the amplicon mixed 
with oligonucleotides complementary to the oncogene SNP sequence  5'-
GAGBCGATTTCAT-3'  where B = PyC or PyU.  The results using the probe 
showed the same fidelity as traditional sequencing techniques, effectively 
identifying the point mutation in much less time and effort, and presumably at 
a much reduced cost and with better sensitivity. 
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 Wagenknecht and co-workers have also used pyrene as a fluorescent 
sensor for SNP detection.38 The pyrene was attached with no spacer linking it 
to the guanine base, giving fluorobase PyG; also synthesised was a 7-
deazaguanine base, Z (Figure 1.6).   The fluorescence of the PyG base was 
quenched in the presence of a flanking SNP compared to the matched 
sequence.   It was found that the quenching could be made even more 
dramatic if Z was incorporated in an [5' (n+3) 3'] position in the 
oligonucleotide.  
 
 
Figure 1.6:  Synthetic nucleosides employed by Wagenknecht and co-workers.38 
 
In a similar fashion, Saito and co-workers have also used perylene 
(PerU) and anthracene (2AntU , 9AntU) based tags as SNP sensors (Figure 
1.7).39  In both cases, as before, the fluorescent group was directly attached 
to the uracil base under Sonagashira conditions.  The perylene version of the 
tag was found to be useful for detection of mismatches in short 
oligonucleotides, displaying an increase in fluorescence at 496 nm for a PerU-
C mismatch compared to the matched PerU-A base pair.  It was proposed that 
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behaviour was due to the expulsion of the intercalating perylene into the bulk 
polar solvent when a base pair match occurs.  When mismatch occurs as the 
perylene gains limited flexibility to intercalate into the non-polar double-helix 
and fluorescence is switched off.     
 
 
Figure 1.7:  Perylene and anthracene based SNP sensors.39 
 
Likewise, the anthracene tags were found to be useful as SNP 
sensors.   Sharing the same ethylene linker as the perylene and pyrene 
versions of the tag, the anthracene fluorescence was observed to increase 
under mismatch conditions.    2AntU was able to effectively discriminate 
between A and C in the anti-sense strand, giving a large increase in 
fluorescence for A, and quenching for C.  Little difference in fluorescence 
intensities were found for oligonucleotide duplexes containing G and T 
compared to the 2AntU tagged single strand DNA.  2AntU  was also found to be 
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much more suited than 9AntU to the role due to its greater relative 
fluorescence increase at longer wavelengths, even more so than the pyrene 
derivatives discussed previously.   
 
Brown and co-workers reported the use of the thymine analogues NeT, 
AeT, and AeeT which utilised anthracene and naphthalene fluorescent groups 
as SNP sensors (Figure 1.8).40   Each thymine analogue was found to behave 
the same, undergoing fluorescence enhancement for a matched target 
sequences and quenching for T-G mismatch.    It was also found that if 
thymine tagged with fluorescein was also incorporated into the same 
oligonucleotide with the hydrocarbon probes then the fluorescein fluorescence 
was also enhanced upon duplex formation in all cases.  This led the authors 
to speculate on the design of probes with dual function. 
 
 
Figure 1.8:  Naphthlanene and anthracene thymine analogues for SNP detection.40 
 
Tucker and co-workers have also found success in the development of 
novel SNP sensors based on fluorescent anthracene dyes, though the 
approach varies to that of Saito in that the tag is not actually appended to a 
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base. Rather, a non-nucleosidic diol-containing anthracene is first synthesised 
and then modified to be incorporated into the DNA via the BC 
phosphoramidite method (Figure 1.9).41   
 
 
 
Figure 1.9:  Anthracene tag used by Moran et al. for SNP detection.41 
 
 The fluorescence intensity was quenched nearly 100% upon duplex 
formation with a fully complementary strand (target C-G base pair flanking the 
anthracene position) of DNA compared to the single stranded tagged 
oligonucleotide.  Upon target mismatch (target C-A base pair flanking the 
anthracene position), the fluorescence was increased by almost 200%, 
allowing stark definition between matched and mismatched flanking base 
pairs.  The fluorescence quenching observed for the matched target 
sequences was attributed to intercalation of the anthracene into the non-polar 
interior of the duplex. This was backed up by the higher melting temperatures 
for the anthracene tagged matched duplex compared to the analogous non-
tagged matched duplex, the intercalated anthracene serving to stabilise the 
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helix in the former case.  The increase in fluorescence upon flanking C-A 
mismatch could not easily be explained, though it was postulated that 
expulsion of the anthracene from the interior of the duplex could be a very 
likely possibility, due to the relative instability of the mismatch sequences by 
melting temperature. The authors state that a range of linker and spacer 
lengths will be used to investigate the remarkable fluorescence behaviour of 
the probe. 
  
 Asseline et al. recently unveiled a sensor for the detection of SNPs at 
the 5'-termini  in oligonucleotides, n-TO (where n = 4 – 7), incorporating the 
organic dye thiazole orange attached to the sugar-phosphate backbone by a 
thiophosphate ester (Figure 1.10). 42  It was found that the sensor was not 
only able to sense SNPs by an increase in fluorescence under mismatch 
conditions, but it was also able to discriminate between G-A, A-G, T-T, C-C, 
C-T and T-C mismatches; the authors state that these SNP mutations are 
reported to be among the hardest for cellular repair mechanisms to distinguish 
from matched base pairs, citing the work by Kramer et al.43  The mechanism 
of the sensing was again believed to be due to differences in local 
environment polarity in and around the oligonucleotides, with conformational 
changes induced by mismatch leading to perturbed fluorescence. 
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Figure 1.10: Terminal SNP sensor incorporating thiazole orange.42 
 
Tor and co-workers synthesised an SNP sensor based on thieno[3,4-
d]pyrimidine, (Figure 1.11), which was incorporated into RNA oligonucleotides 
by enzymatic catalysis using T7 RNA polymerase.44  The incorporation of 
labels into oligonucleotides by enzymatic methods offered several 
advantages, for instance not having to engage in protecting group chemistry,  
extremely high efficiency, production of large amounts of oligonucleotides and 
being able to change the label easily.  Once incorporated into the RNA 
sequences, the fluorescent properties were tested with duplex formation to 
place the four conventional DNA bases opposite to the fluorescent synthetic 
base.  The emission where the thieno[3,4-d]pyrimidine probe was opposite to 
C gave the largest emission increase, over 7-fold compared to the to the 
perfect duplex where the thieno[3,4-d]pyrimidine is paired with A.   
Mismatches with T and G opposite to the thieno[3,4-d]pyrimidine base, 
although enhanced, were not as strong as the enhancement observed for the 
thieno[3,4-d]pyrimidine – A mismatch.  It was concluded that the sensor was 
specific for the latter SNP. 
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Figure 1.11:  Thiopyrimidine base-discriminating fluorescent ribonucleoside. 
 
A slightly different approach has been used by Sigurdsson and co-
workers.  A cytosine analogue was synthesised by reduction of a spin label to 
give the highly fluorescent nucleoside Çf, with quantum efficiency in excess of 
30% (Figure 1.12).    It was found upon incorporation into oligonucleotide 
sequences that the modified base could successfully identify each of the four 
bases in the adjacent position on the opposite strand as the fluorescence 
readout was so different for each base pair upon duplex formation.   The Çf-A 
mismatch gave the brightest fluorescence, with the fully matched Çf-T 
sequence the least fluorescent.  Of the other two remaining combinations,   
Çf-G and Çf-C could be distinguished due to the striking green-blue colour of 
the Çf-G fluoresence.  It was also demonstrated that the fluorescence 
behaviour was independent of the flanking base pair in the sequence, which is 
important for developing robust SNP sensors for universal use. 
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Figure 1.12:  Highly fluorescent SNP sensor developed by Cekan et al.45 
 
1.8. Conclusion.  
 It is clear from this brief introduction and review of some highlights from 
the literature that this is an exciting area of research with the aim of medical 
diagnosis as the major driving force in the area.  The discovery of new SNP 
sensors for rapid and cheap analysis of point mutations in genes is extremely 
important for the future of this field of medicine.   In the next chapter, the 
synthesis of a new nucleotide analogue 5a for future incorporation into DNA 
oligonucleotides will be described, as well as the incorporation of another 
synthetic nucleoside analogue 5b into DNA oligonucleotides and the 
subsequent studies into detection of SNPs in a range of target oligonucleotide 
sequences. 
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2.0. Results and Discussion. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1:  Definitions of 'spacer' and 'linker' in anthracene SNP probes. 
 
It was decided that a new anthracene-based SNP sensor for use in 
small DNA oligonucleotides should be synthesised.  In a previous 
communication on sensing SNPs in short oligonucleotide sequences,41 the 
anthracene group was appended directly to the sugar phosphate backbone 
using the Beaucage-Caruthers synthetic cycle.   Such sensors have two 
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variables which can be modified. These are, firstly, the length of the ‘linker’, 
which corresponds to the number of carbon centres (n) between the 
anthracene and the amide bond, and, secondly, the nature of the spacer that 
is attached via a phosphodiester linkage upon incorporation into a DNA 
oligonucleotide (Figure 2.1).    Clearly as discussed in the introduction section, 
the change in the fluorescence in probes of this type is highly dependent on 
the geometry that the probe finds itself in under match and mismatch 
conditions.  Changing the length of the linker and the nature of the spacer in a 
systematic manner would be key to understanding the remarkable behaviour 
that was exhibited by the originally communicated anthracene probe.  
 
 
2.1. Synthesis of anthracene tag 5a for mismatch detection in DNA 
duplexes. 
 
The synthetic scheme which was used to produce the n = 1 
phosphoramidite 5a is shown in Scheme 2.1.  Briefly, there are five synthetic 
steps in the scheme; the first stage uses an ether synthesis to install the ester 
group, the second stage is a simple saponification to the corresponding 
carboxylic acid, the third stage employs traditional solution-phase peptide 
chemistry with coupling reagents to produce the diol via amide linkage, the 
fourth stage is the mono O-protection of the diol with the dimethoxytrityl 
(DMTr) group. and the fifth and final stage in the chemical synthesis 
transforms the remaining free hydroxyl group into an activated 
phosphoramidite.  The final molecule can then be entered into a round of 
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automated DNA synthesis to install it as a synthetic base in an oligonucleotide 
sequence of choice. 
 
 
 
 
Scheme 2.1:  Synthesis of SNP probe precursor 5a. 
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 The reaction between anthrone and ethyl bromoacetate in the 
presence of potassium carbonate proceeded as expected, giving the crude 
product which was purified using flash column chromatography to give the 
product ester 1 in respectable yield.  1H NMR spectroscopy (Figure 2.2) was 
used to confirm the successful synthesis of the purified product with the 
appearance of the ethyl ester quartet and triplet peaks at 4.29 and 1.29 ppm, 
and the signal for the methylene protons appearing as a 2H singlet at 4.72 
ppm.  These peaks in the aliphatic region integrated correctly against the 
aromatic region which confirmed that the appendage was in the correct ratio.  
Electrospray mass spectrometry gave the expected RMM for 1 as the 
monosodium adduct; high resolution mass spectrometry was also used to 
determine the exact mass of the compound which, when compared to a 
theoretical calculation of exact mass for 1 gave an almost identical mass, 
within 2 ppm.  
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δ  /  ppm 
Figure 2.2:  1H NMR spectrum of 1 (300 MHz, CDCl3). 
  
Ester 1 was then converted to the carboxylic acid 2 by saponification.  
A mixture of ethanol-water was used to aid the solubility of the starting 
material, but it was still a slurry to begin with.  The reaction was monitored by 
TLC using the solvent system employed for the synthesis of the ester, with the 
disappearance of the ester peak used to gauge the end of reaction.  The 
reaction mixture became a complete solution by the end of the reaction due to 
the formation of the carboxylate sodium salt of 2, the latter being soluble in 
polar solvents.  The crude product was isolated by precipitation after 
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acidification to pH 1 with concentrated hydrochloric acid to ensure complete 
protonation of the carboxylate (pKa ~ 4.5). 1H NMR spectroscopy was useful in 
the identification of the product due to the simple nature of the transformation; 
the only changes in the spectrum of 2 compared to 1 were the disappearance 
of the quartet and triplet ester CH2 and CH3 peaks, previously seen at 4.29 
ppm and 1.29 ppm. The signal for the methylene protons remained intact and 
in the correct ratio to the aromatic peaks by integration.  Mass spectrometry 
verified the correct mass of the molecule. Due to the unduly clean 1H NMR 
trace it was decided that further purification was not required.  Consequently, 
the reaction proceeded in excellent overall yield (90%).   
 
The chemistry to produce diol 3, which involved the condensation of 
diethanolamine with 2 proved more problematic.  The success of the reaction 
seemed to hinge on finding a suitable peptide coupling agent for the reaction; 
a number of failed reactions in the laboratory occurred where only starting 
material was recovered from the reaction using the coupling agents 
benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate (PyBOP) 
and hydroxybenzatriazole (HOBt).  Use of varying equivalents of these 
coupling reagents also did not seem to help matters.  Eventually our attention 
was turned to using the coupling reagent O-Benzotriazole-N,N,N’,N’-
tetramethyluronium hexafluorophosphate  (HBTU) at a molar ratio of 1.5:1 
coupling agent to 2.  We were able to isolate a pure product in poor yield 
(13%) after column, though with acceptable purity.   Attempts were made to 
improve the yield of the reaction, using longer reaction times but this did not 
seem to have any effect.   Mass spectrometry was used to confirm that the 
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condensation occurred successfully, with a peak for the monosodium adduct 
at m/z 362.  The high resolution mass of this peak was also an excellent 
match to the calculated exact mass, within 1.5 ppm.  We also used elemental 
analysis to confirm the ratio of C, H and N in the product; the results showed 
that we had isolated the product as a dihydrate, which made sense in terms of 
the hydrogen bonding capabilities of the diol pendant arms, one water bound 
to each.    The 1H NMR spectrum (Fig 2.3) of compound 3 was the most 
interesting result of all.    Evidence of product formation came from the 
appearance of the four triplet peaks in the range 3.84 – 3.29 ppm.   These 
peaks correspond to the four CH2 centres on the diethanolamide arms. Each 
triplet integrated to 2H, in the correct ratio to both the aromatic peaks 
originating from anthracene group and the aliphatic singlet corresponding to 
the resonance of the methylene linker CH2.  Free rotation around the amide 
bond therefore has to be slower than the NMR timescale at 298 K, which 
explains why there are four triplets as opposed to two; the protons on each of 
the diethanolamide arms can be discerned from each other spectroscopically. 
This effect is particularly common for amides, as rotation around the N-C 
bond is restricted due to partial π character. 13C NMR gave the expected 
number of carbon environments required at the expected chemical shifts.   
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δ  /  ppm 
 
Figure 2.3:  1H NMR spectrum of 3 (300 MHz, 1:1 CD3CN / CDCl3). 
 
Protection of the first hydroxyl group was achieved using 
dimethoxytrityl chloride (DMTrCl) in the presence of a catalytic amount of 
dimethyl aminopyridine (DMAP). In order to give a predominantly mono O-
protected product, only one molar equivalent of the DMTrCl was used.  Even 
so, the product required purification by chromatography to remove what was 
presumably a polyfunctionalised by-product, though the yield (40%) was 
considered to be excellent for a mono-protection in the presence of a 
competing group.  Formation of the product was confirmed by electrospray 
mass spectrometry, giving a single peak with m/z 663, the monosodium 
adduct of the molecule.  High resolution mass spectrometry also confirmed 
the exact mass experimentally matched the theoretical mass.   1H NMR of 4a 
again showed evidence of restricted rotation around the amide bond observed 
in 3,  in this case due to the signal for the methylene linker protons (H6) being 
now split into two separate signals, each integrating to effectively half of the 
original H6 signal.  This was ascribed to the mono O-functionalisation of 4a 
with DMTr, and it was investigated by 2D  1H-13C HSQC NMR spectroscopy.  
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Cross peaks are observed in this spectrum for protons that are linked to 
carbon centres by 1 bond i.e. C-H bonds.  The two split signals for H6 were 
observed to show a cross peak to only one carbon centre (Figure 2.4).   
 
 
 
Figure 2.4:  HSQC spectrum of 4a showing the C6-H6 cross-peak (1:1 
CD3CN/CDCl3). 
 
To confirm that the restricted rotation around the amide bond was the 
reason for the splitting seen in the 1H NMR spectrum, variable temperature 
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NMR (VT-NMR) was used to probe the phenomena, in conjunction with Dr L. 
Giordano.  Firstly, a 1H NMR spectrum of a sample containing 4a was taken 
at 300 K.  This was followed by heating to a range of temperatures;   
successive 1H NMR spectra were taken at 318 K and 333 K.  The results 
confirmed that the splitting of the peaks was due to restricted rotation around 
the amide bond, as the peaks merged into one peak as the temperature was 
successively increased (Figure 2.5). 
 
 
 
Figure 2.5:  VT-NMR experiment monitoring H6 in product 4a (300 MHz, CD3CN). 
 
The magnitude of the energy barrier with which had to be overcome to 
ensure rotation of the bond was then calculated as follows.  First of all, the 
exchange rate between the two conformations at the coalescence 
temperature (Tc, estimated to be 333 K) was calculated using the following 
equation:46 
+ 27 °C / 300 K 
+ 45 °C / 318 K 
+ 60 °C / 333 K 
H6 
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kex = (π •Δν)  /  (√ 2)    (eq. 1) 
 
Where Δν is the difference in frequency for the separate sharp line signals at 
+27 °C.  For our signals, Δν = 2015.1 Hz – 1998.6  Hz  =  16.4 Hz. 
 
Hence,   
 
 kex = 35.5 s-1 at 333 K. 
 
 
The free energy of activation, ΔGex‡, was also calculated by using the 
following equation: 
 
ΔGex‡ = R  ×  Tc(K) [ 23 + ln (Tc(K) / Δν) ]            (eq. 2) 
 
R is the gas constant (8.31 x 10-3  kJ K-1 mol-1 ).   
 
Therefore,    
 
ΔGex‡  =  72  kJ mol-1 at 333 K. 
 
In comparison, Tc = 331 K for the rotation of the amide bond in N,N-
dimethylacetamide, due to delocalisation of the nitrogen lone pair.47  N,N,-
dimethyl formamide also has a similar coalesence temperature of 337 K.46   
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These latter two standard are similar to the calculated value here.   It can 
therefore be concluded that the results for 4a are fully consistent with 
restricted rotation around the amide bond due to partial π character (Figure 
2.6).    It is worth noting that as stated earlier, the coalescence temperature is 
an estimate, in this case, only two NMR spectra were taken at elevated 
temperatures, and the Tc temperature of 333K is likely to be an upper limit. 
 
 
 
Figure 2.6:  Partial π character of the C-N bond in N, N-dimethylformamide.   
 
 The purified product 4a was then reacted further to make the activated 
phosphoramidite precursor to be incorporated into DNA oligonucleotides.    
Briefly, 4a was reacted with 2-cyanoethyl-diisopropylchlorophosphoramidite, 
in the presence of di-isopropylamine.  The reaction was very fast, taking only 
1 hour to go to completion as evidenced by thin layer chromatography.    The 
product, 5a, was produced in acceptable yield (34%).    31P {1H, 13C} NMR 
was extremely useful in demonstrating the incorporation of phosphorus in the 
molecule, with two peaks appearing at 149 ppm corresponding to the 
incorporation of the phosphoramidite; although a singlet would be expected, it 
seems that the effect of the restricted rotation around the amide bond also 
splits the phosphoramidite peak into two separate signals even in this 
product.48   Mass spectrometry of the reaction product gave the correct mass 
for 5a, at m/z 864, with high resolution mass giving close to the calculated 
 
ΔGex‡ ~ 90 kJ mol-1 
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value.  Due to time constraints, no further work was performed to incorporate 
the label into DNA oligonucleotides, though it is expected that in the near 
future this task will be completed, and the fluorescence properties of the 
probe sequences examined when paired with matching and mismatching 
sequences, the latter containing SNPs.  The results will be very interesting to 
compare against the original anthracene probe discussed previously:  
although the linker is of the same length in 5a as the original probe, the 
spacer distance is slightly larger in 5a, hence the effect of this change should 
give significant insight into the importance of this variable. 
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2.2. Anthracene tag 5b for single base-pair mismatch detection in DNA 
duplexes: synthesis, incorporation into DNA oligonucleotides and 
photochemistry with target sequences. 
 It was also decided to investigate the behaviour of a tag containing a 
chiral spacer group due to the chiral nature of DNA itself, B-DNA existing as a 
right handed helix.  It was anticipated that probes derived from 5b (Scheme 
2.2), containing a D-threoninal linker with the two chiral centres in (2S, 3S) 
configuration, would interact with single-stranded and duplex DNA in a 
extremely different manner than to the (2S, 3R), (2R, 3S) or (2R, 3R) variants, 
resulting in different fluorescence profiles both before and after hybridisation.  
In addition, the linker length was relatively large and would allow comparison 
with probes containing a shorter linker length.   
 
 
 
Scheme 2.2: Synthesis of SNP probe precursor 5b, containing a D-threoninal linker. 
 
 The mono O-protected product 4b was supplied by Mr J. -L. Duprey 
from this research group, and was fully characterised at the point of use.25 4b 
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was reacted with 2-cyanoethyl- N, N -diisopropylchlorophosphoramidite (in an 
identical manner to that discussed previously for the synthesis of 5a) to give 
the activated product 5b.  The reaction product was characterised by 31P {1H, 
13C} NMR which demonstrated the phosphorus incorporation.  Electrospray 
mass spectrometry gave the correct mass for the sodium adduct of 5b at m/z 
935.  Again, reaction time was very short as evidenced by thin layer 
chromatography, ~ 1 hour, and occurred in fair yield (59%).  
 
2.2.1. Oligonucleotide synthesis. 
 5b was then incorporated into oligonucleotide sequences using an 
automated DNA synthesiser (see experimental for further details).   A range of 
oligonucleotides containing the fluorescent probe were synthesised.  The 
tagged sequences were fourteen natural bases in length plus the single 
synthetic anthracene 5b.  Only the base pairs flanking the anthracene tag 
were changed between different probes.   The probe sequences were purified 
by HPLC, followed by desalting using size-exclusion chromatography (Nap-10 
column, GE Healthcare).  The incorporation of the probe was verified using 
negative ion mode electrospray mass spectrometry, which gave excellent 
matches for every probe sequence compared to the calculated value.  A 
summary of probe sequences and calculated vs. experimental mass can be 
found in Table 2.1 (see appendix for mass spectra).  The concentration of 
each synthesised probe (not shown) was determined by UV-Vis absorption 
spectroscopy (Beer-Lambert law) using the value of the absorption value at 
260 nm and molar absorptivities. The latter was calculated by adding together 
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the molar absorptivities of the individual bases in the sequence and that of 
anthracene.  
 
Table 2.1:  Summary of probe sequences and their experimentally determined masses. 
 
Designation Sequence Calc. RMM m/z (obs.) 
PrA 5'-TGGACTC5bCTCAATG-3' 4710.3 4711.0 
PrB 5'-TGGACTC5bGTCAATG-3' 4750.3 4751.0 
PrC 5'-TGGACTC5bATCAATG-3' 4734.3 4735.0 
PrD 5'-TGGACTC5bTTCAATG-3' 4725.3 4726.0 
PrE 5'-TGGACTG5bCTCAATG-3' 4750.3 4751.0 
PrF 5'-TGGACTA5bCTCAATG-3' 4734.3 4735.0 
PrG 5'-TGGACTT5bCTCAATG-3' 4725.3 4727.0 
 
In the same way, a range of target DNA sequences were synthesised 
using automated solid phase synthesis followed by purification by HPLC and 
desalting using size exclusion chromatography.  These sequences were 
comprised of both 15-mer and 14-mer strand lengths.  The 14-mer strand 
length targets were included to test the effect of base deletion on the target 
strand adjacent to the anthracene unit, allowing the latter group to intercalate 
more effectively between bases in the DNA duplex.  The latter effect, which 
stabilises the DNA duplex, has been elegantly illustrated in the article by 
Fukui et al. on intercalation of acridine into oligonucleotide sequences (Figure 
2.7). 49 
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Figure 2.7:  Intercalative geometries with deletion sequences (left) and sequences 
with a base in the adjacent strand (right).49 
 
 
 A summary of the target sequences is shown in Table 2.2.  The 
concentrations of the synthesised target sequences (not shown) were 
determined by UV-Vis absorption spectroscopy using the absorption value at 
260 nm, as for the probe sequences.  
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Table 2.2:  Summary of target sequences.  "_" refers to a base deletion. 
 
Target Sequence Length 'Matched' Probe  Opp.  
Base‡ 
TarA1 3'-ACCTGAGAGAGTTAC-5' 15-mer PrA A 
TarA2 3'-ACCTGAG_GAGTTAC-5' 14-mer PrA del 
TarA3 3'-ACCTGAGTGAGTTAC-5' 15-mer PrA T 
TarA4 3'-ACCTGAGCGAGTTAC-5' 15-mer PrA C 
TarA5 3'-ACCTGAGGGAGTTAC-5' 15-mer PrA G 
TarB1 3'-ACCTGAGACAGTTAC-5' 15-mer PrB A 
TarB2 3'-ACCTGAG_CAGTTAC-5' 14-mer PrB del 
TarC1 3'-ACCTGAGATAGTTAC-5' 15-mer PrC A 
TarC2 3'-ACCTGAG_TAGTTAC-5' 14-mer PrC del 
TarD1 3'-ACCTGAGAAAGTTAC-5' 15-mer PrD A 
TarD2 3'-ACCTGAG_AAGTTAC-5' 14-mer PrD del 
TarE1 3'-ACCTGACAGAGTTAC-5' 15-mer PrE A 
TarE2 3'-ACCTGAC_GAGTTAC-5' 14-mer PrE del 
TarF1 3'-ACCTGATAGAGTTAC-5' 15-mer PrF A 
TarF2 3'-ACCTGAT_GAGTTAC-5' 14-mer PrF del 
TarG1 3'-ACCTGAAAGAGTTAC-5' 15-mer PrG A 
TarG2 3'-ACCTGAA_GAGTTAC-5' 14-mer PrG del 
 
‡ 'Opp. base' refers to the base opposite anthracene unit in the probe-target duplex. 
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Figure 2.8: CD spectra of duplexes with matched sequences. Top: 14-mer / 15-mer target-
probe duplexes. Bottom: 15-mer / 15-mer target-probe duplexes. 
 
2.2.2.  Circular dichroism studies. 
Circular dichroism (CD) spectra of the matched and mismatched 
duplexes were recorded to give insight into the solution structure of the 
sequences (Figures 2.8 and 2.9, see pull-out sheet for sequence details).   
CD signals arise from the difference in absorbance between incident left- and 
right-handed circularly polarised radiation by a chiral molecule.  Due to its 
right-handed helicity, B-DNA is inherently chiral, and so produces a CD signal 
at 250 nm, which mirrors its UV-Vis absorbance spectrum.  Changes to the 
helicity of the DNA, i.e. transformation to other polymorphs such as the Z-form 
in solution, result in alterations to the profile of the CD spectrum.  All of the 
matched and mismatched 14-mer / 15-mer and 15-mer / 15-mer target-probe 
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duplexes show the typical circular dichroism expected from DNA in solution in 
the B-form, with a negative peak at 250 nm corresponding to the CD signal of 
the aromatic base pairs i.e. the duplexes are still helical in structure. The 
cause of the differences in peak amplitudes is possibly due to minor 
differences in the helicity of the probe-target duplexes. The incorporation of 
the anthracene into the DNA duplexes cannot be discerned at these 
concentrations. At higher concentrations, one would expect CD signals at 300 
- 400 nm corresponding to the well known finger-like absorbances of the 
vibronic fine structure in anthracene.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.9:  CD spectra of mismatch duplexes with probe A. Top: 15-mer / 15-mer probe- 
target duplexes. Bottom: 14-mer / 15-mer target-probe duplexes.   
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2.2.3. DNA melting experiments. 
The melting temperatures (Tm) of matched probe-target duplexes were 
investigated by UV-Vis absorption spectroscopy.  Melting refers to the 
temperature at which the DNA duplex dissociates into two single strands, 
which is accompanied by a change in the UV-Visible spectrum of the sample 
under scrutiny.  The same measurements were also performed on a range of 
mismatched sequences using probe A (PrA) alone on all the target 
sequences, Bx – Gx (where x = 1 – 2). The UV-Vis instrument (Varian Cary 
5000) used in this study allowed the automated recording of melting 
temperatures (using a ramp from 15 – 85 °C;  Tm values reported are an 
average of two runs on the same sample, the second run preceded by an 
annealing cool-down step to re-hybridise the double stranded DNA duplex), 
which are reported in Table 2.3.     Note the 3' / 5' designation in the 
polymorphism type column refers to the location of the mismatch on the 
flanking bases with respect to the probe strand, rather than the target strand.  
Taking the example of PrA hybridised with TarB1: 
 
5'-TGGACTC5bCTCAATG-3'  PrA 
 3'-ACCTGAGACAGTTAC-5'  TarB1 
 
would lead to a shorthand description of the mismatch as 3' C-C.    
Conversely, the example of PrA hybridised with Tar E1: 
 
5'-TGGACTC5bCTCAATG-3'  PrA 
3'-ACCTGACAGAGTTAC-5'  TarE1 
 
would lead to the mismatch descriptor 5' C-C.   
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Table 2.3:  DNA melting temperatures for matched and mismatched probe-target duplexes. 
 
'Matched' sequences 
 
 'Mismatched' sequences 
Probe Target Tm (°C)  Probe Target Tm (°C) 
 
Mismatch 
type  
PrA TarA1 52.5  PrA TarB1 34.0 
 
3' C-C 
 
PrA TarA2 58.5  PrA TarB2 40.5 
 
3' C-C 
PrA TarA3 55.0  PrA TarC1 40.5 
 
3' C-T 
PrA 
 
TarA4 54.5  PrA TarC2 43.0 3' C-T 
PrA TarA5 55.0  PrA TarD1 41.0 
 
3' C-A 
 
PrB TarB1 50.0  PrA TarD2 43.0 
 
3' C-A 
 
PrB TarB2 57.0  PrA TarE1 44.0 
 
5' C-C 
 
PrC 
 
TarC1 49.0  PrA TarE2 44.5 5' C-C 
PrC 
 
TarC2 56.0  PrA TarF1 40.5 5' C-T 
PrD 
 
TarD1 46.0  PrA TarF2 43.5 5' C-T 
PrD 
 
TarD2 50.0  PrA TarG1  41.0 5' C-A 
 
PrE 
 
TarE1 51.0  PrA TarG2 43.5 5' C-A 
 
PrE 
 
TarE2 56.5  
PrF TarF1 47.0  
PrF TarF2 53.0  
PrG TarG1  47.0  
PrG TarG2 51.5  
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 The melting temperature of a DNA double helix is indicative of its 
inherent stability.  It is well known that intercalating molecules such as 
anthracene increase the stability of the DNA double helix, and as such, the 
melting temperature of a duplex containing an intercalator is usually higher 
compared to the same duplex without the intercalator present.   
 
The effect of anthracene intercalation in matched sequences is 
demonstrated nicely by considering the PrATarAx (where x = 1 – 5) duplex 
melting temperatures (Figure 2.10, see pull-out sheet for sequence details).  It 
can be seen from the graph that PrATarA2 (14-mer deletion target) gives the 
largest melting temperature.  This is due to the extra space afforded by the 
deletion in the target strand in the position adjacent to the anthracene on the 
probe strand, as anthracene can intercalate more effectively in this case.   
The same can also be said for all of the deletion duplexes (Pr: 15-mer / Tar: 
14-mer, x =2) versus the 15-mer duplexes (Pr: 15-mer / Tar: 15-mer,  x = 1) 
e.g. PrBTarB2 vs. PrBTarB1 (ΔTm = +7 °C) ; again, the increase in the 
melting temperature observed are due to improved intercalation from the 
anthracene tag caused by base deletion (refer to Figure 2.7).    
 
The effect of changing the base in the target strand opposite to the 
anthracene in the probe strand is not as pronounced an effect as base 
deletion.  This can be seen by comparing the Tm of the PrATarA1 against the 
PrATarAx (where x =  3, 4, 5) sequences.   The melting temperature is 
slightly increased for the sequences where T, C and G are opposite the 
anthracene though the effect is small and for these 15-mer duplexes it may be 
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concluded that the degree of anthracene intercalation is probably very similar; 
hence the effect of the base opposite to anthracene does not influence the 
intercalative ability of the anthracene tag in any significant way. 
 
 
 
Figure 2.10: Melting temperatures of matching probe-target duplexes.  Data for 15-mer / 14-
mer deletion duplexes are coloured grey. 
 
   The melting temperatures of the mismatched sequences compared to 
the matched sequences are dramatically depressed, due to the loss of a 
matched base pair.   In addition to this, the effect of anthracene intercalation 
in the sequences containing PrA hybridised with various mismatching target 
sequences is similar to that observed for the matched sequences, though is 
less marked (Figure 2.11, see pull-out sheet for sequence details);  in general, 
the duplexes containing deletion target strands (Pr: 15-mer / Tar: 14-mer) are 
of slightly higher melting point than their 15-mer duplex counterparts.  This 
again is due to the improved ability of the anthracene to intercalate through 
base deletion on the target strand.  However, as these sequences contain 
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mismatches (see Table 2) both in upstream and downstream flanking 
positions, the hydrogen bonding in the cavity is imperfect and the intercalation 
of the anthracene is obstructed by the base pair mismatch, hence the melting 
temperature increase is not as prominent compared to the fully matched 
sequences.    The trend in melting temperature for 15-mer / 14-mer 
sequences is also general for 3' and 5' flanking SNPs, which demonstrates 
the effect is purely due to the increased anthracene intercalation found in 
these duplexes. 
. 
 
Figure 2.11:  Melting temperatures of mismatch duplexes incorporating probe A. Data for 15-
mer / 14-mer deletion duplexes are coloured grey. 
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2.2.4. Fluorescence studies. 
 Fluorescence involves the relaxation from the lowest level of an excited 
singlet state to the singlet ground state, ejecting a photon of energy.  This is 
usually preceded by excitation into the excited state by absorbance of a 
photon of higher energy than that emitted.  The difference between the 
absorbance maximum and the emission maximum, called the Stokes shift, 
arises from vibrational relaxation in the upper state.  The process can be 
summarised26  in simplified schemes known as Jablonski diagrams (Scheme 
2.3).  
 
 
 
Scheme 2.3:  Jablonski diagram showing the typical process involved in anthracene 
fluorescence (left) and a cartoon of an absorption-fluorescence profile (right). 
 
 The excited state may also be deactivated (quenched) by radiationless 
transitions, such as collisions with other molecules. The extent of the 
quenching is often dependent on the environment in which the excited 
fluorescent molecule finds itself in.  It is well known that polar environments 
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tend to enhance the molecular fluorescence in polyaromatic hydrocarbons 
(e.g. anthracene), whereas non-polar environments (such as anthracene 
intercalated between the aromatic bases of DNA) quench the fluorescence as 
the extent of radiationless decay is greater. 34 
 
The quenching or enhancement of anthracene fluorescence when 
appended to DNA oligonucleotides is the basis of the SNP sensors designed 
in this laboratory.  We decided to investigate the changes in anthracene 
fluorescence by titration of probes sequences containing appended 
anthracene against mismatched target sequences at 0, 0.5, 1.0, 1.5 and 2.0 
equivalents.   A selection of probe-target sequences were selected from the 
set of duplex sequences which were used in the melting temperature 
experiments for comparative purposes. 
 
 
Table 2.4: Summary of results for matching duplexes with probe A. 
 
 
 
Probe Target Tm (°C) Opposite base 
(target strand) 
Final Relative 
Fluorescence 
Change 
PrA TarA1 52.5 A +171% 
PrA TarA2 58.5 Delete -18% 
PrA TarA3 55.0 T -41% 
PrA TarA4 54.5 C +31% 
PrA TarA5 55.0 G +110% 
 
The nature of the matched probe-target sequences for probe A 
(PrATarAx, where x = 1 – 5) were investigated by fluorescence titration 
(Figure 2.12, see pull-out sheet for sequence details).       Converse to the 
melting temperature results, it was found that varying, or indeed deletion of, 
the base in the opposite strand in the position adjacent to the anthracene 
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probe had a direct influence over the relative fluorescence of the anthracene 
in the duplex compared to the single strand probe A.   If a larger purine base 
(G, A) is used opposite the anthracene in the duplex, as in PrATarA1 and 
PrATarA5, the fluorescence of the anthracene increases dramatically upon 
duplex formation, over 110% in both cases.   The smaller pyrimidine bases (T, 
C) tend to give opposite effects to each other, with a C base opposite giving a 
31% increase (PrATarA4), and a T base giving a 41% decrease (PrATarA3).   
The duplex sequence where a deletion was made in this position (PrATarA3) 
gave a smaller 18% reduction in relative fluorescence compared to the tagged 
single strand oligonucleotide, PrA (Table 2.4).  We concluded from the 
melting temperature experiments that the anthracene unit is intercalated, and 
in the duplexes with a base opposite the anthracene the degree of 
intercalation is similar (apart from PrATarA1, which displays a depressed Tm) 
, so these results imply that the fluorescence behaviour of 5b within the probe 
A strand is dependent on the base opposite in the target strand if the flanking 
base pairs remain the same (in this case the flanking base pairs are GC in 
both upstream and downstream directions).   
 
By consideration of the fluorescence process, it is apparent that the 
non-radiative decay of the excited state of the anthracene is either 
suppressed (in the case of the larger purine bases A and G and also to a 
lesser extent the smaller pyrimidine, C) or enhanced (in the case of T and 
deletion).  It may be postulated that purine bases, due to their larger size may 
prevent full anthracene intercalation, and that the anthracene fluorescence is 
enhanced by partial expulsion into the polar environment of the bulk solvent.  
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We may say that this is the case for PrATarA1, which shows a depressed Tm 
compared to the other matched sequences with PrA. However, this would 
certainly be an incorrect conclusion to make; the result from PrATarA4 
disagrees with the result from PrATarA1 , as this also has a purine base 
opposite anthracene, but has a similar melting temperature to matched 
duplexes with a pyrimidine base adjacent to anthracene, hence intercalation 
should not be a factor.   The behaviour of the anthracene unit in PrA upon 
duplex formation may therefore simply rely on how efficient the base opposite 
either quenches or enhances the fluorescence from the excited state.  The 
latter effect has been communicated by Netzel and co-workers50 who reported 
the magnitude of fluorescence quenching by the four DNA bases to be as 
follows:  C > T > G > A.  This is mirrored in our results, where the C and T 
bases in the opposite strand lead to relatively reduced fluorescence compared 
to their A and G counterparts.    It is reasonable therefore to suggest that a 
second factor is in play: the expulsion of the anthracene unit into a binding 
pocket.  This effect has been observed in the binding of aptamers (which are 
short nucleic acid sequences designed to sequester target sequences or 
fluorescent dyes), to fluorescent organic dye molecules such as malachite 
green leading to either dramatic quenching or enhancement of the 
fluorescence signal. 51 
 
  In the case of the deletion (14-mer/15-mer) duplex PrATarA2, the 
anthracene unit in PrA is intercalated between two GC base pairs, which are 
known to quench anthracene fluorescence, 41 hence the decrease observed.  
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The discovery of this behaviour may be important of the fine tuning of 
SNP sensors based on anthracene in future applications, in particular tuning 
the selectivity of the probe. 
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Table 2.5: Summary of results for mismatch duplexes with probe A. 
 
Probe Target Tm (°C) 
 
Duplex 
type 
Mismatch 
type 
Final Relative 
Fluorescence 
Change 
PrA TarB1 34.0 15 – 15 3' C-C +5% 
PrA TarB2 40.5 15 - 14 (del) 3' C-C  -18% 
PrA TarC1 40.5 15 - 15 3' C-T +19% 
PrA TarC2 43.0 15 - 14 (del) 3' C-T  -31% 
PrA TarD1 41.0 15 - 15 3' C-A +44% 
PrA TarD2 43.0 15 - 14 (del) 3' C-A  -25% 
PrA TarE1 44.0 15 - 15 5' C-C +38% 
PrA TarE2 44.5 15 - 14 (del) 5' C-C  -1% 
PrA TarF1 40.5 15 - 15 5' C-T +2% 
PrA TarF2 43.5 15 - 14 (del) 5' C-T  -32% 
PrA TarG1  41.0 15 - 15 5' C-A +43% 
PrA TarG2 43.5 15 - 14 (del) 5' C-A  -2% 
 
Figure 2.12:  Fluorescence titration, matched PrATarAx duplexes (λex = 350 nm, λem = 426 
nm). 
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Figure 2.13:  Fluorescence titration, mismatched PrATar duplexes (λex = 350 nm, λem = 426 
nm).  Hash lines / triangles: 14-mer / 15-mer deletion duplexes. Solid lines / squares: 15-mer / 
15-mer duplexes. 
 
 To determine whether PrA had potential to be an SNP sensor, 
the mismatched PrA-target duplexes were investigated by fluorescence 
titration (Figure 2.13, also see pull-out sheet for sequence details).   PrA was 
titrated against a number of target sequences TarBx - TarGx, each with a 
mismatch (x = 1 targets) or a mismatch plus base deletion in the target strand 
(14-mer / 15 mer duplex, target x = 2).     In the x = 1 sequences, the base 
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opposite to the anthracene in the target strand was adenine (A).  The results 
fell into three categories.  Target sequences were either found to i) enhance, 
ii) quench or iii) have little effect on the anthracene unit's fluorescence.    The 
results are summarised in Table 2.5.   
 
  It was found that for mismatches in the 14-mer / 15-mer sequences (x 
= 2) on the whole led to quenching of fluorescence compared to PrA alone, or 
simply no effect from hybridisation.  From the melting temperature 
experiments in the mismatch sequences, it was clear that in general the 14-
mer / 15-mer duplexes gave better anthracene intercalation from the higher 
melting temperatures compared to the 15-mer duplexes. Hence in these 
sequences the anthracene residue is intercalated in the non-polar 
environment of the DNA helix.   As a result, the anthracene emission is 
quenched or simply not enhanced at all.  The results from PrATarC2 and 
PrATarF2, where quenching is of a similar magnitude, demonstrates that the 
position of C-T mismatches, either upstream or downstream compared to 
anthracene, does not influence the probe response (3' C-T plus deletion, -
31% vs. 5' C-T plus deletion, -32%).  The result for PrATarF1 is probably 
erroneous due to the shape of the curve, fluorescence decreasing after 1 eq. 
of target. 
 
  Conversely, for the sequences with the adjacent base to anthracene 
included (PrA  vs. TarBx – Gx where  x = 1) the anthracene fluorescence was 
either enhanced or unaffected.  The signal of the anthracene in PrA was 
enhanced greatly with the flanking mismatches created upon duplex formation 
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with in TarC1 (3' C-T , +19%), TarD1 (3' C-A, +44%), TarE1 (5' C-C, +38%) 
and TarG1 (5' C-A, +43%).    The probe response for C-A mismatches in 
PrATarD1 and PrATarG1 duplexes is particularly striking, giving a sizeable 
enhancement in fluorescence intensity that is independent of upstream or 
downstream position of the mismatch relative to the anthracene unit.  The 
flanking position seems to play a much more pivotal role in the case of C-C 
mismatches, where mutation in the 5' direction (on the probe strand) leads to 
a distinct fluorescence enhancement, compared to the same mutation 3' 
direction (PrATarB1 vs. PrATarE1).    The reverse effect is true for C-T 
SNPs, where fluorescence is enhanced for the SNP in the 3' direction, and 
unaffected for the same SNP in the 5' direction (PrATar C1 vs. PrATarF1).  
The reasons for the differences in the latter two examples i.e. the dependence 
on the flanking bases, could be due to the chiral nature of the anthracene 
probe and its relative ability (or inability) to interact with the DNA due to the 
steric demands imposed by certain base pairs.   
 
 The fluorescence enhancements again are linked to the melting 
temperatures found for the 15-mer (x = 1) duplexes, which in general show 
decreased stability compared to their 15-mer / 14-mer duplex counterparts (x 
= 2).  It is expected that there is less prominent anthracene intercalation in the 
duplexes, and as such the anthracene is more likely to be expelled into the 
polar bulk solvent outside the double helix, or placed into an aptamer-like 
binding pocket;51 the latter have been known to enhance fluorescence of 
organic molecules upon binding. Computer modelling of the latter 
interactions should be considered to shed more light on the interesting effects 
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discovered, and should specifically explore the spatial location of the 
anthracene upon duplex formation to shed light on the mechanism of 
fluorescence enhancement.   
 
 
 
 
2.3. Conclusions 
 In conclusion, firstly, a new fluorescent anthracene unit, 5a, has been 
synthesised for incorporation into DNA oligonucleotides and use in SNP 
sensing.   
 
Secondly, we synthesised and incorporated a chiral anthracene unit, 
5b, into DNA oligonucleotides.  We found that there were differences in the 
melting temperature (Tm) of 14-mer/15-mer and 15-mer/15-mer duplexes, 
almost certainly due to improved anthracene intercalation into the double helix  
in the former case.  Fluorescence titrations of PrA versus a range of matched 
targets demonstrated the effect of base deletion in the adjacent position to the 
anthracene on the target strand, and the dependence of anthracene 
fluorescence on the base opposite in the target strand; adenine leads to the 
strongest enhancement of the anthracene fluorescence signal. Fluorescence 
titrations of PrA versus a range of mismatched targets demonstrate a turn-on 
effect, especially for C-A mismatches.  This latter effect is independent of 
upstream/downstream (3' / 5') direction with respect to the anthracene unit.   
The same turn-on effect was seen for C-T and C-C mismatches, though the 
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turn-on for both was highly dependent on the SNP position (5' / 3') relative to 
the probe, probably due to the chiral nature of the probe. 
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3.0. Experimental 
General 
Reagents were purchased from Aldrich or Acros.  Solvents were 
purchased from Fisher or Aldrich.  NMR solvents were purchased from 
Aldrich.   UV-Vis spectra were recorded on a Varian Cary 5000 spectrometer 
with a peltier temperature controller for DNA melting experiments.     
Fluorescence experiments were carried out using a Shimadzu fluorimeter.    
NMR spectra were recorded on Bruker AVIII300 and Bruker AVIII400 
spectrometers.  Solid state IR spectra were recorded using a crystal stage.    
Electrospray mass spectra were recorded on a LC-TOF Micromass 
instrument.  Elemental analysis was performed using a Carlo Erba EA1110.   
All synthetic procedures were carried out under dry nitrogen. 
 
 
 
Anthracen-9-yloxy acetic acid ethyl ester (1). 
 
 
 
Anthrone  (5.83g, 0.03 mol) and potassium carbonate (4.15g, 0.03 mol) 
were dissolved in acetone (200 ml) and stirred under nitrogen at room 
temperature in the absence of light for 15 minutes.  Ethyl bromoacetate (3.3 
ml, 0.03 mol) was added and reaction mixture heated under reflux for 16 
hours.  The solution was filtered and dichloromethane (100 ml) and water (50 
ml) added.  After vigorous shaking, the aqueous layer was run off and the 
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organic layer dried over magnesium sulfate.  The dichloromethane was 
removed under vacuum to leave an orange oil, which solidified on standing.  
The ester (Rf = 0.58) was purified on silica eluting hexane with 10% ethyl 
acetate to give a fluffy pale yellow solid  (2.50 g, 30%).   Analytical data 
agreed with that previously published by Moran et al.52 TLC (Chloroform on 
silica):  Rf = 0.58 .  1H NMR (300 MHz, CDCl3), δ ppm: 8.29 (2H, d, J = 1.0, 
H1), 8.18 (1H, s, H5), 7.91 (2H, d, J= 7.5, H4),  7.41 (4H, m, H2 / H3), 4.72 
(2H, s, H6), 4.29 (2H, q, J = 7.2, CH2CH3), 1.29, (2H, t, J = 7.2, CH2CH3).  MS 
(ES) m/z: 303 (M+Na). HRMS (ES) calcd for C18H16O3Na: 303.0997,  found:  
303.0991.  IR (νmax, solid state) cm-1:  1764 (s, C=O, ester), 1204 (s, C-O, 
ester). 
 
Anthracen-9-yloxy acetic acid (2). 
 
 
 
Anthracen-9-yloxy acetic acid ethyl ester (1, 4.50 g, 0.01 mol) was dissolved 
in a 1:1 solution of 10% aqueous sodium hydroxide and ethanol (200 ml) and 
heated at 90 °C overnight in the absence of light. The solution was 
concentrated under reduced pressure and the residue dissolved in water (500 
ml).  36% hydrochloric acid was added drop-wise to the solution to precipitate 
a solid which filtered. The solid was washed with water (20 ml) and dried to 
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give the desired product as a pearlescent, cream solid (90%. 3.65 g)   No 
further purification was required.  Analytical data agreed with that previously 
published by Moran et. al.52 ).  Elemental analysis calcd for C16H12O3:  C 
76.18%,   H 4.79%,  found: C 76.18%,  H  4.44%.  1H NMR (300 MHz, CD3CN 
/ CDCl3), δ ppm:  8.28 (1H, s, H5), 8.26 (2H, d, J = 6.7, H1), 8.00 (2H, d, J = 
6.7,  H4), 7.48 (4H, m, H2 / H3), 4.77 (2H, s, H6). MS (ES) m/z: 251 (M-H). 
HRMS (ES) calcd for C16H11O3: 251.0708 , found:  251.0710.  IR (νmax, solid 
state) cm-1:  3100 (w, COOH), (s, w, COOH).   
 
2-(Anthracen-9-yloxy)-N-( 1-hydroxymethyl-2-hydroxy-ethyl)-acetamide 
(3). 
 
 
Anthracen-9-yloxy acetic acid (2, 2.00 g, 7.9 mmol, 1.0 eq.) was 
dissolved in anhydrous N, N- dimethylformamide (55 ml). O-benzotriazole-
N,N,N'N'-tetramethyl uronium hexafluorophosphate ("HBTU", 4.51 g, 11.9 
mmol, 1.5 eq.) was added to the solution followed by di-isopropylethylamine 
(1.26 ml, 0.93 g, 7.2 mmol, 0.9 eq.) and the solution stirred under N2 at room 
temperature in the absence of light for 15 minutes. Diethanolamine (0.76 g, 
7.2 mmol, 0.9 eq.) was added and the reaction was heated to 40 °C and 
stirred for 40 hours, after which time, the solution was diluted into a mixture of  
1:2 methanol/dichloromethane (100 ml) which was washed with water (3 x 
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50ml) and dried over magnesium sulfate.  The solvent was removed under 
reduced pressure to give the crude product as yellow oil.   Purification by 
silica column chromatography (Gradient from DCM with 1% MeOH via DCM 
with 3% MeOH to finally DCM with 5% MeOH) gave the desired product as a 
pale yellow solid (0.31 g, 13%). TLC (5% MeOH in DCM on silica): Rf = 0.15.    
1H NMR (300 MHz, CD3CN/CDCl3), δ ppm:  8.26 (2H, d, J = 6.0,  H1), 8.11 
(1H, s, H5), 7.86 (2H, d, J = 6.0, H4), 7.35 (4H, m, H2 / H3), 4.89 (2H, s, H6), 
3.84 (2H, t, J = 3.6, H8), 3.62 (2H, t, J= 3.0 H7), 3.54 (2H, t, J = 3.6, H8'), 3.28 
(2H, t, J= 3.0, H7').  13C PENDANT NMR (100 MHz, CD3CN/CDCl3) δ ppm:  
169.5 (C=O, amide), 152.0 (C-O of C14H9), 131.5 (C of C14H9), 127.5 (CH of 
C14H9), 124.9 (CH of C14H9), 124.8 (CH of C14H9),123.6 (C of C14H9), 121.8 
(CH of C14H9), 121.5 (C of C14H9), 72.3 (CH2O), 59.6 (CH2 ethanolamide), 
58.6 (CH2 ethanolamide), 49.6 (CH2 ethanolamide), 48.7 (CH2 ethanolamide). 
MS (ES) m/z: 362 (M+Na)+.  HRMS (ES) calcd for C20H21NO4Na: 362.1368, 
found: 362.1372.   IR (νmax, solid state) cm-1:  3354 (br, OH), 1624 (s, C=O 
amide). 
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2-(Anthracen-9-yloxy)-N-(1-dimethoxytrityl-2-hydroxy-ethyl)-acetamide 
(4a). 
 
 
2-(Anthracen-9-yloxy)-N-(1-hydroxymethyl-2-hydroxy-ethyl)-acetamide 
(3, 0.15 g, 0.44 mmol, 1.0 eq.) was dissolved in anhydrous pyridine (3 ml) and 
to it added dimethoxytrityl chloride (0.15 g, 0.44 mmol, 1.0 eq.) and 4-
dimethylamino pyridine (5.3 mg, 43 µmol, 10 mol%).  The mixture was stirred 
for 24 hours at room temperature, then poured into water (25 ml).  The 
aqueous phase was washed with dichloromethane (2 × 25 ml) and the 
combined organic extracts dried over magnesium sulfate, filtered then the 
solvent removed under reduced pressure to give the orange-yellow crude 
product, which was purified by chromatography on a silica column eluting 
99% hexane : 1% triethylamine, eluant increasing in polarity after sample 
loading was complete to 50% hexane : 49% ethylacetate, 1% triethylamine, to 
give the 4a as a pale yellow solid  (0.11 g, 40%) . TLC (5% MeOH in DCM, 
silica) :  Rf = 0.35.  1H NMR (300 MHz, CD3CN), δ ppm: 8.29 (3H, m, H5 /H1), 
7.98 (2H, d, H4), 7.40 (6H, m, H2/3, trityl), 7.25 (2H, m, trityl), 7.18 (1H, m, 
trityl), 7.05 (4H, m, trityl), 6.79 (2H, m trityl), 6.57 (2H, m, trityl),  4.97 (1H, s, 
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H6), 4.93 (1H, s, H6'), 3.67 (3H, s, trityl), 3.63 (3H, s, trityl), 3.53 (2H, m), 3.36 
(2H, t, J = 3.0, CH2 ethanolamide, ), 3.19 (1H, t, J = 3.6, CH2 of 
ethanolamide), 3.11 (1H, t, J = 3.6, CH2 ethanolamide), 3.00 (1H, t, J = 3.0, 
CH2 of ethanolamide), 2.93 (1H, t, J = 3.0, CH2 ethanolamide).  13C 
PENDANT NMR (100 MHz, CD3CN) δ ppm:  170.0 (C=O, amide), 159.0 (C-O 
of C14H9), 146.4  (C, trityl),  146.2 (C, trityl), 138.4 (C, trityl) 137.8 (C, trityl), 
135.0 (CH, trityl) 132.1 (C of C14H9), 129.6 (CH, trityl), 129.4 (CH,  trityl), 
128.0 (CH, trityl), 127.5 (CH of C14H9) 127.4 (CH, trityl), 126.5 (CH, trityl), 
125.4 (CH of C14H9), 125.3 (CH of C14H9), 122.3 (C of C14H9), 122.2  (CH of 
C14H9),  112.7 (CH, trityl) 112.6 (CH, trityl), 73.0 (CH2O), 61.1 (CH2 
ethanolamide), 61.1 (CH2 ethanolamide), 61.0 (CH2 ethanolamide), 59.6 (CH2 
ethanolamide), 59.6 (CH2 ethanolamide), 58.8 (CH2 ethanolamide)   54.5 
(OMe, trityl), 49.3 (CH2 ethanolamide), 48.4 (CH2 ethanolamide), 47.5 (CH2 
ethanolamide), 45.2, (CH2 ethanolamide).  MS (ES) m/z: 664 (M+Na).  HRMS 
(ES) calcd for C41H39NO6Na : 664.2675,  found:  664.2705.  IR (νmax, solid 
state) cm-1:  3280 (br, OH), (s, C=O amide). 
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2-(Anthracen-9-yloxy)-N-(1-dimethoxytrityl-2-(2-cyanoethyl 
diisopropylamino phosphoramidite))-acetamide (5a). 
 
 
 
2-(Anthracen-9-yloxy)-N-(1-dimethoxytrityl-2-hydroxy-ethyl)-acetamide 
(4a, 0.11 g, 0.17 mmol, 1.0 eq.) was dissolved in anhydrous dichloromethane 
(5 ml) and diisopropylamine (0.09 ml,  0.07 g, 0.51 mmol,  3.0 eq.) added 
,followed by stirring for 15 minutes.  2-cyanoethyl-N,N-diisopropyl 
chlorophosphoramidite (0.04 ml, 0.04 g, 0.18 mmol, 1.1 eq.) was added 
dropwise to the solution followed by stirring at room temperature for 1 hour in 
the absence of light.   Polymer bound benzyl alcohol (0.1 g) was then added 
and stirring was continued for a further 30 minutes.  The solids were filtered 
off then the solvent removed under reduced pressure.  To the residue was 
added ethyl acetate (5 ml) and 2 M aqueous sodium bicarbonate (5 ml) with 
agitation, and the aqueous layer run off.   The organic layer was washed with 
brine (5 ml) and dried using magnesium sulfate.  The ethyl acetate was 
removed under reduced pressure to leave a crude residue which was purified 
on activated basic alumina with methanol as the eluant to give the final 
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product , 5a (0.05 g, 34%) after removal of solvent under reduced pressure.  
31P NMR (121 MHz, CD3CN), δ ppm: 148.0 (s , phosphoramidite), 147.6 (s , 
phosphoramidite).  m/z (ES):  864 (M+Na)+.  HRMS (ES) m/z calcd for 
C50H56N3O7PNa: 864.3754, found 864.3745.    
 
7-(Anthracen-9-yloxy)-N-((2S,3S)-1-(bis(4-
methoxyphenyl)(phenyl)methoxy)-3-hydroxybutan-2-yl)heptanamide 
(5b). 
 
 
2-(Anthracen-9-yloxy)-N-(1-dimethoxytrityl-2-hydroxy-ethyl)-acetamide 
(4b, 0.30 g, 0.42 mmol, 1.0 eq.) was dissolved in anhydrous dichloromethane 
(15 ml) and diisopropylamine (0.21 ml,  0.17 g, 1.3 mmol,  3.0 eq.) added, 
followed by stirring for 15 minutes.  2-cyanoethyl-N,N-diisopropyl 
chlorophosphoramidite (0.10 ml, 0.10 g, 0.45 mmol, 1.1 eq.) was added 
dropwise to the solution followed by stirring at room temperature for 1 hour in 
the absence of light.   Polymer bound benzyl alcohol (0.25 g) was then added 
and stirring was continued for a further 30 minutes.  The solids were filtered 
off then the solvent removed under reduced pressure.  To the residue was 
added ethyl acetate (10 ml) and 2 M aqueous sodium bicarbonate (10 ml) with 
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agitation, the aqueous layer was then run off.   The organic layer was washed 
with brine (10 ml) and dried using magnesium sulfate.  The ethyl acetate was 
removed under reduced pressure to leave a crude residue which was purified 
on activated basic alumina with methanol as the eluant to give the final 
product  , 5b (0.23 g,  59%) after removal of solvent under reduced pressure.      
31P NMR (121 MHz, CD3CN), δ ppm: 147.6 (s , phosphoramidite), 146.9 (s , 
phosphoramidite) MS (ES) m/z: 935 (M+Na). HRMS (ES) calcd for 
C55H66N3O7PNa : 934.4536 , found:  934.4573. 
 
 
General procedure for oligonucleotide synthesis. 
 Synthesis of probe and target sequences were performed using an 
automated ABI 394 DNA/RNA synthesiser running Oligonet 1.0 software.  
Final base deprotection was achieved by heating the oligonucleotides 
(released from the machine into solution containing ammonia), at 55 °C in a 
sealed vial for 6 hours.    
 
The solvents were removed under reduced pressure then the residue 
re-dissolved in water (1 ml).  The absorbance at 260 nm was measured by 
taking 10 µl of the oligonucleotide and mixing with 990 µl water, and then 
used to calculate oligonucleotide concentrations and hence yields.  
Preparative HPLC purification of the oligonucleotides was performed on a 
reversed phase column eluting a 0.1 M triethylammmonium acetate / 
acetonitrile gradient. Oligonucleotides were desalted on Nap-10 size 
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exclusion columns (GE Healthcare) to give the final products. Desalted probe 
sequences were characterised by electrospray mass spectrometry. 
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Probe sequences synthesised. 
 
Designation Sequence Calc. RMM m/z (obs.) 
PrA 5'-TGGACTC5bCTCAATG-3' 4710.3 4711.0 
PrB 5'-TGGACTC5bGTCAATG-3' 4750.3 4751.0 
PrC 5'-TGGACTC5bATCAATG-3' 4734.3 4735.0 
PrD 5'-TGGACTC5bTTCAATG-3' 4725.3 4726.0 
PrE 5'-TGGACTG5bCTCAATG-3' 4750.3 4751.0 
PrF 5'-TGGACTA5bCTCAATG-3' 4734.3 4735.0 
PrG 5'-TGGACTT5bCTCAATG-3' 4725.3 4727.0 
 
Target sequences synthesised. 
 
Target Sequence 
TarA1 3'-ACCTTGAGAGGAGTTAC-5' 
TarA2 3'-ACCTTGAG_GGAGTTAC-5' 
TarA3 3'-ACCTTGAGTGGAGTTAC-5' 
TarA4 3'-ACCTTGAGCGGAGTTAC-5' 
TarA5 3'-ACCTTGAGGGGAGTTAC-5' 
TarB1 3'-ACCTTGAGACGAGTTAC-5' 
TarB2 3'-ACCTTGAG_CGAGTTAC-5' 
TarC1 3'-ACCTTGAGATGAGTTAC-5' 
TarC2 3'-ACCTTGAG_TGAGTTAC-5' 
TarD1 3'-ACCTTGAGAAGAGTTAC-5' 
TarD2 3'-ACCTTGAG_AGAGTTAC-5' 
TarE1 3'-ACCTTGACAGGAGTTAC-5' 
TarE2 3'-ACCTTGAC_GGAGTTAC-5' 
TarF1 3'-ACCTTGATAGGAGTTAC-5' 
TarF2 3'-ACCTTGAT_GGAGTTAC-5' 
TarG1 3'-ACCTTGAAAGGAGTTAC-5' 
TarG2 3'-ACCTTGAA_GGAGTTAC-5' 
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Appendix 
 
Product:  1. 
 
1H NMR (300 MHz, CDCl3). 
 
 
 
δ  /  ppm 
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Product:  2. 
 
1H NMR (300 MHz, CD3CN / CDCl3). 
 
Aromatic assignments identical to product 1. 
 
 
δ  /  ppm 
Product:  3. 
 
1H NMR (300 MHz, CD3CN / CDCl3). 
 
 
 
 
δ  /  ppm 
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13C PENDANT NMR (100 MHz, CD3CN/CDCl3). 
 
 
 
 
Product:  4a. 
 
1H NMR (300 MHz, CD3CN). 
 
 
 
Aliphatic region 
EtOAc 
H6 
trityl H13 
 
H7, 8, 9, 10 
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13C PENDANT NMR (100 MHz, CD3CN).   
 
 
 
 
 
 
Aromatic region 
H1,4  
 
H1,4 
H5 
trityl H15, 14 
 
H2, 3 
trityl H11, 12, 16  
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Product:  5a. 
 
31 P NMR (121 MHz, CD3CN). 
 
 
 
 
Product:  5b. 
 
31 P NMR (121 MHz, CD3CN). 
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Probe A 
 
ES (-) 
 
 
 
 
Probe B 
 
ES (-) 
 
 
 
 
Probe C 
 
ES (-) 
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Probe D 
 
ES (-) 
 
 
 
 
 
 
Probe E 
 
ES (-) 
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Probe F 
 
ES (-) 
 
 
 
Probe G 
 
ES (-) 
 
 
 
 
 
 
 
 
 
 
   
